NASDAQ:INCR InterCure Q4 2025 Earnings Results & Report $4.98 -0.05 (-1.01%) Closing price 10/9/2026 03:57 PM EasternExtended Trading$4.99 +0.01 (+0.22%) As of 10/9/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. InterCure reported Q4 2025 earnings on April 30, 2026. The company reported EPS of -$0.50, while revenue was $23.15 million. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ4 2025Report DateApril 30, 2026TimeBefore Market Opens InterCure EPS ResultsActual EPS-$0.50Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AInterCure Revenue ResultsActual Revenue$23.15 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesEarnings HistoryCompany Profile InterCure Q4 2025 Earnings FAQ Did InterCure beat earnings estimates for Q4 2025? InterCure (NASDAQ:INCR) reported earnings of -$0.50 per share for Q4 2025. The report was announced on Thursday, April 30, 2026. What was InterCure's revenue for Q4 2025? InterCure reported revenue of $23.15 million for Q4 2025. InterCure Earnings HeadlinesTilray Brands (NASDAQ:TLRY) and InterCure (NASDAQ:INCR) Head-To-Head SurveyOctober 2, 2026 | americanbankingnews.comInterCure Regains Nasdaq Compliance After Delisting WarningSeptember 8, 2026 | tipranks.comFederal Reserve Reveals Disturbing New Plan To Control Your MoneyDocket No. OP-1670 is drawing attention for what it reveals about the Federal Reserve's next move. Buried on page 84 is a plan that could expand oversight of checking accounts, purchases, and money transfers across the country. Martin D. Weiss, PhD, founder of Weiss Ratings, breaks down what this document means and why it could roll out as soon as this summer.October 10 at 1:00 AM | Weiss Ratings (Ad)InterCure Regains Compliance with Nasdaq Minimum Bid Price RequirementSeptember 8, 2026 | globenewswire.comInterCure (INCR) Finalized a $77M Settlement, but How Much New Cash Will it Receive?August 27, 2026 | insidermonkey.comInterCure Raises $5 Million in August Private Placement to Rebuild Nir Oz FacilityAugust 26, 2026 | tipranks.comSee More InterCure Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like InterCure? Sign up for Earnings360's daily newsletter to receive timely earnings updates on InterCure and other key companies, straight to your email. Email Address About InterCureInterCure (NASDAQ:INCR), operating under the Canndoc brand, is a vertically integrated cannabis company focused primarily on the medical cannabis market. The company’s activities include cannabis cultivation, processing, manufacturing, distribution and the sale of cannabis products through authorized channels. InterCure offers medical cannabis flower and other cannabis-based products under brands including Canndoc and related consumer and medical product lines. Its business has historically been centered in Israel, where it operates within the country’s regulated medical cannabis framework and serves patients through licensed distribution channels and pharmacies. Founded in 2013, InterCure has also pursued international expansion through partnerships, exports and market-development initiatives in selected overseas jurisdictions, including parts of Europe. The company is publicly traded on the Nasdaq Capital Market under the symbol INCR and on the Toronto Stock Exchange.View InterCure ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 10/05 - 10/09Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November EarningsApplied Digital’s Hidden Moat Could Unlock Massive UpsideLevi's Stock Dip Reveals Value Opportunity Despite Q3 HeadwindsTilray Finds a Path to Growth Without Waiting on U.S. Cannabis ReformPepsiCo Stock Looks Poised to Bottom With High Yield, Deep ValueMicrosoft Is Almost Back to $555—Now the Hard Part Begins Upcoming Earnings Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026)BlackRock (10/14/2026)Morgan Stanley (10/14/2026)Progressive (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
